Kelyniam Global, Inc. (KLYG)
USD 0.18
(0.06%)
USD 0.18
(0.06%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.01 Million USD | 7.15% |
| 2022 | 945.32 Thousand USD | 28.08% |
| 2021 | 738.07 Thousand USD | -11.73% |
| 2020 | 836.13 Thousand USD | -33.09% |
| 2019 | 1.24 Million USD | 92.49% |
| 2018 | 649.16 Thousand USD | 16.39% |
| 2017 | 557.75 Thousand USD | -9.25% |
| 2016 | 614.61 Thousand USD | 11.46% |
| 2015 | 551.43 Thousand USD | -3.9% |
| 2014 | 573.78 Thousand USD | -13.24% |
| 2013 | 661.32 Thousand USD | 0.0% |
| 2007 | 139.92 Thousand USD | 28.61% |
| 2006 | 108.79 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 817.03 Thousand USD | -1.25% |
| 2024 Q1 | 827.34 Thousand USD | -18.32% |
| 2023 Q4 | 1.01 Million USD | 11.76% |
| 2023 Q1 | 912.19 Thousand USD | -3.5% |
| 2023 Q3 | 906.32 Thousand USD | 3.57% |
| 2023 FY | 1.01 Million USD | 7.15% |
| 2023 Q2 | 875.12 Thousand USD | -4.06% |
| 2022 Q3 | 777.04 Thousand USD | -10.3% |
| 2022 Q1 | 793.9 Thousand USD | 7.56% |
| 2022 FY | 945.32 Thousand USD | 28.08% |
| 2022 Q4 | 945.32 Thousand USD | 21.66% |
| 2022 Q2 | 866.24 Thousand USD | 9.11% |
| 2021 Q2 | 685.19 Thousand USD | -27.24% |
| 2021 Q3 | 599 Thousand USD | -12.58% |
| 2021 Q4 | 738.07 Thousand USD | 23.22% |
| 2021 FY | 738.07 Thousand USD | -11.73% |
| 2021 Q1 | 941.72 Thousand USD | 12.63% |
| 2020 Q2 | 1.1 Million USD | 6.22% |
| 2020 FY | 836.13 Thousand USD | -33.09% |
| 2020 Q4 | 836.13 Thousand USD | -23.51% |
| 2020 Q3 | 1.09 Million USD | -1.48% |
| 2020 Q1 | 1.04 Million USD | -16.41% |
| 2019 FY | 1.24 Million USD | 92.49% |
| 2019 Q4 | 1.24 Million USD | 33.05% |
| 2019 Q3 | 939.17 Thousand USD | 30.45% |
| 2019 Q2 | 719.92 Thousand USD | 2.25% |
| 2019 Q1 | 704.07 Thousand USD | 0.0% |
| 2018 FY | 649.16 Thousand USD | 16.39% |
| 2017 FY | 557.75 Thousand USD | -9.25% |
| 2016 FY | 614.61 Thousand USD | 11.46% |
| 2015 FY | 551.43 Thousand USD | -3.9% |
| 2014 Q4 | 573.78 Thousand USD | -11.9% |
| 2014 FY | 573.78 Thousand USD | -13.24% |
| 2014 Q3 | 651.27 Thousand USD | 0.0% |
| 2014 Q1 | 672.77 Thousand USD | 0.0% |
| 2013 Q1 | 675.86 Thousand USD | 0.0% |
| 2013 FY | 661.32 Thousand USD | 0.0% |
| 2013 Q2 | 870.91 Thousand USD | 28.86% |
| 2008 Q1 | 145.27 Thousand USD | 3.82% |
| 2007 Q3 | 118.58 Thousand USD | -0.75% |
| 2007 FY | 139.92 Thousand USD | 28.61% |
| 2007 Q1 | 102.77 Thousand USD | 0.0% |
| 2007 Q4 | 139.92 Thousand USD | 18.0% |
| 2007 Q2 | 119.48 Thousand USD | 16.26% |
| 2006 FY | 108.79 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Avitar, Inc. | 11.59 Million USD | 91.263% |
| BioElectronics Corporation | 16.62 Million USD | 93.906% |
| CVR Medical Corp. | - USD | -Infinity% |
| IR-Med Inc. | 634 Thousand USD | -59.769% |
| Medical Supply International USA, Inc. | 677.61 Thousand USD | -49.485% |
| Polarean Imaging plc | 2.58 Million USD | 60.747% |
| AVITA Medical, Inc. | 19.86 Million USD | 94.901% |
| Manhattan Scientifics, Inc. | 2.11 Million USD | 52.175% |
| Össur hf. | 688.8 Million USD | 99.853% |
| Zecotek Photonics Inc. | 5.86 Million USD | 82.74% |
| QHSLab, Inc. | 2.05 Million USD | 50.758% |
| Wellstar International, Inc. | 55.99 Million USD | 98.191% |
| Össur hf. | 688.8 Million USD | 99.853% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 16.08 Million USD | 93.701% |
| Escalon Medical Corp. | 2.94 Million USD | 65.644% |
| Aurora Spine Corporation | 6.65 Million USD | 84.776% |
| BrainsWay Ltd. | 15.31 Million USD | 93.386% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 6.01 Million USD | 83.153% |
| Hamilton Thorne Ltd. | 45.84 Million USD | 97.79% |
| Vivos Inc. | 245 Thousand USD | -313.436% |
| MicroPort Scientific Corporation | 2.48 Billion USD | 99.959% |
| REMSleep Holdings, Inc. | 275.61 Thousand USD | -267.519% |
| CYduct Diagnostics, Inc. | 2.44 Million USD | 58.652% |
| Nanomix Corporation | 14.81 Million USD | 93.163% |
| Theraclion SA | 13.01 Million EUR | 92.218% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 5.12 Million USD | 80.232% |
| Positron Corporation | 2.02 Million USD | 50.003% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.62 Million USD | 72.027% |
| Lombard Medical, Inc. | 53.79 Million USD | 98.117% |
| ALR Technologies Inc. | 24.5 Million USD | 95.866% |
| Stratec SE | 271.97 Million USD | 99.628% |
| Vycor Medical, Inc. | 4.31 Million USD | 76.54% |
| Heart Tronics, Inc. | 1.09 Million USD | 7.477% |
| Nu-Med Plus, Inc. | 2.35 Million USD | 57.057% |
| Perimeter Medical Imaging AI, Inc. | 5.47 Million USD | 81.504% |
| SANUWAVE Health, Inc. | 65.59 Million USD | 98.456% |
| VMS Rehab Systems, Inc. | 201.36 USD | -502946.782% |
| Guided Therapeutics, Inc. | 5.47 Million USD | 81.499% |
| Ingen Technologies, Inc. | 5.7 Million USD | 82.259% |
| Odyssey Group International, Inc. | 6.61 Million USD | 84.68% |
| United American Healthcare Corporation | 119 Thousand USD | -751.206% |
| ECGI Holdings, Inc. | 11.94 Million USD | 91.517% |
| Capital Group Holdings, Inc. | 1.32 Million USD | 23.493% |
| ADM Tronics Unlimited, Inc. | 1.44 Million USD | 29.965% |
| Urologix, Inc. | 12.64 Million USD | 91.989% |
| Rapid Therapeutic Science Laboratories, Inc. | 5.39 Million USD | 81.228% |
| Nexeon MedSystems Inc. | 8.48 Million USD | 88.058% |
| SS Innovations International, Inc. | 11.18 Million USD | 90.941% |
| Qualis Innovations, Inc. | 525.38 Thousand USD | -92.798% |
| Smith & Nephew plc | 4.76 Billion USD | 99.979% |
| NIOX Group Plc | 9.8 Million USD | 89.666% |
| Fuse Medical, Inc. | 15.11 Million USD | 93.296% |
| Broncus Holding Corporation | 10.43 Million USD | 90.29% |
| Brain Scientific Inc. | 7.42 Million USD | 86.36% |
| Pressure BioSciences, Inc. | 33.8 Million USD | 97.003% |
| Health Logic Interactive Inc. | 794.08 Thousand USD | -27.561% |